In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa
about
In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In Vitro Exposure to PC-1005 a ...... ction in Human Cervical Mucosa
@en
In Vitro Exposure to PC-1005 a ...... tion in Human Cervical Mucosa.
@nl
type
label
In Vitro Exposure to PC-1005 a ...... ction in Human Cervical Mucosa
@en
In Vitro Exposure to PC-1005 a ...... tion in Human Cervical Mucosa.
@nl
prefLabel
In Vitro Exposure to PC-1005 a ...... ction in Human Cervical Mucosa
@en
In Vitro Exposure to PC-1005 a ...... tion in Human Cervical Mucosa.
@nl
P2093
P2860
P356
P1476
In Vitro Exposure to PC-1005 a ...... ction in Human Cervical Mucosa
@en
P2093
Barbara Friedland
Craig J Hoesley
George W Creasy
Giulia Calenda
Guillermo Villegas
José A Fernández-Romero
Kyle Kleinbeck
Michael L Cooney
Natalia Teleshova
Olga Mizenina
P2860
P304
P356
10.1128/AAC.00392-16
P407
P577
2016-07-05T00:00:00Z